English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
Novotech Webinar: Why the Asia-Pacific is Attracting 10,000 Oncology Trials and How Biotechs Can Tap the Region
Jul 13, 2020 19:00 HKT
A Free Bitcoin Tax Solution for This Season
Jul 13, 2020 18:00 HKT
UNISOC Completes Equity Restructuring, Promotes IPO Process
Jul 13, 2020 17:00 HKT
HRCとポル・エスパルガロ選手の契約が合意
Jul 13, 2020 17:00 HKT
HRCとアレックス・マルケス選手が契約更新に合意
Jul 13, 2020 17:00 HKT
노보텍 (Novotech) 웨비나: 아시아 태평양 지역이 10,000 건의 종양학 임상시험을 유치하고 있는 이유 및 바이오텍 회사들이 이 지역의 장점을 활용할 수 있는 방안
Jul 13, 2020 17:00 HKT
Novotech網絡研討會:亞太地區為何吸引了多達10,000例腫瘤學試驗,以及生物技術公司如何利用該地區的優勢
Jul 13, 2020 17:00 HKT
Novotech网络研讨会:亚太地区为何吸引了多达10,000例肿瘤学试验,以及生物技术公司如何利用该地区的优势
Jul 13, 2020 17:00 HKT
ソニー、「新型コロナウイルス・ソニーグローバル支援コロナ基金」の支援状況について
Jul 13, 2020 14:00 HKT
Rescheduling of HKTDC Book Fair and other July public fairs
Jul 13, 2020 14:00 HKT
Bega Cheese selects Software AG to provide IoT dairy supply chain solution
Jul 13, 2020 13:00 HKT
香港國安法:中國國安部稱將配合駐港國安公署履行職權
Jul 13, 2020 12:27 HKT
君实生物新冠中和抗体JS016完成I期临床试验受试者入组
Jul 13, 2020 11:48 HKT
CATL and Honda Sign Agreement to Form Comprehensive Strategic Alliance on Batteries for New Energy Vehicles
Jul 13, 2020 11:48 HKT
昭和電工、「イソシアネートモノマーと粘接着・塗料分野の応用」で2020年度第42回日本接着学会技術賞を受賞
Jul 13, 2020 11:30 HKT
Eisai: Industry-Academia-Government Joint Development Agreement Aiming for Drug Discovery for Systemic Lupus Erythematosus by Practical Application of Toll-Like Receptor Research Concluded
Jul 13, 2020 10:47 HKT
NEC、New Normal時代の新しい働き方をDXで実現するデジタルオフィスのプロジェクト始動
Jul 13, 2020 10:00 HKT
富士通研究所、世界初 教師データなしで高次元データの特徴を正確に獲得できるAI技術を開発
Jul 13, 2020 10:00 HKT
Pudu RoboticsはMeituanから$1500万以上のシリーズBの独占的な投資誘致に成功
Jul 13, 2020 10:00 HKT
Fujitsu Develops World's First AI technology to Accurately Capture Characteristics of High-Dimensional Data Without Labeled Training Data
Jul 13, 2020 09:12 HKT
Next >>
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: